Tod Smeal

Tod Smeal

Chief Tech/Sci/R&D Officer at CARDIFF ONCOLOGY, INC.

Net worth: - $ as of 29/06/2026

61 year
Health Technology
Finance
Consumer Services

Profile

Dr. Tod Smeal is a Chief Scientific Officer at Cardiff Oncology, Inc. Dr. Smeal was previously employed as a Chief Scientific Officer by Hexagon Bio, Inc., a Chief Scientific Officer-Cancer Biology by Eli Lilly & Co., and a Director-Oncology Research Unit by Pfizer Inc. He received his undergraduate degree from Massachusetts Institute of Technology and a doctorate degree from the University of California San Diego.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
13/04/2026 0 ( -.--% ) - $ 29/06/2026

Tod Smeal active positions

CompaniesPositionStart
CARDIFF ONCOLOGY, INC. Chief Tech/Sci/R&D Officer 10/01/2022

Former positions of Tod Smeal

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 31/12/2020
ELI LILLY AND COMPANY Chief Tech/Sci/R&D Officer 31/12/2019
PFIZER INC. Corporate Officer/Principal 31/12/2014
See the detail of Tod Smeal's experience

Training of Tod Smeal

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

92

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology